Celsior® crystalloid cardioplegia versus standard hyperkalemic normothermic blood cardioplegia: Analysis of myocardial protection in elective mitral valve repair.

Margaux PontaillerCharles-Henri DavidPhilippe LacosteGuillaume GuimbretièreBasile MarieChristian PerigaudAntoine MugniotImen FellahJean-Christian RousselThomas Senage

Published in: Perfusion (2021)

Effective myocardial protection was achieved with the Celsior® cardioplegic solution with no unexpected toxicity. Celsior® may be an efficacious and safe cardioprotective strategy in mitral valve repair.

Keyphrases

left ventricular
patients undergoing
oxidative stress